Reuse of single use devices
This article was originally published in The Gray Sheet
Executive Summary
FDA's proposed strategy for regulating reuse of single use medical devices "would continue to ignore the [Food, Drug and Cosmetic Act] and leave patients at risk," the Association of Disposable Device Manufacturers maintains in a Nov. 19 letter to Rep. Fred Upton (R-Mich.). The association expresses support for H.R. 3148, introduced Oct. 26 by Anna Eshoo (D-Calif.) and Upton (1"The Gray Sheet, Nov. 1, p. 6), which "will motivate the FDA to protect U.S. patients from reprocessed single use devices"
You may also be interested in...
House Reprocessed Medical Device Bill May Have Smoother Sailing
Bipartisan support could help facilitate the progress of reprocessed single-use medical device legislation pending in the House during the next congressional session, Hill staffers predict.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.